Bharat Biotech’s Covaxin gets emergency nod for children aged 12-18

As Omicron cases rise in the country, the Drugs Controller General of India (DCGI) has given its approval to Bharat Biotech’s COVID-19 vaccine for kids between 12 -18 years of age for emergency use, with certain conditions.

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech’s EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and has provided their positive recommendations, the vaccine maker had said.

This makes Covaxin the second vaccine cleared for use for children in India.

Credits – Source – https://ift.tt/3qmlUQ9

The post Bharat Biotech’s Covaxin gets emergency nod for children aged 12-18 appeared first on Stay in Gurgaon.

Comments

Popular posts from this blog

Flat sale of flu drugs hints at no unusual rise in infections

10YearsForSimha: Reasons behind film’s success

Hrithik-Saif’s Vikram Vedha hits a roadblock